Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat. - Wikidata - awgldk - TriplyDB

Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat.

Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat.

http://www.wikidata.org/entity/Q37541992

about

Local Intratracheal Delivery of Perfluorocarbon Nanoparticles to Lung Cancer Demonstrated with Magnetic Resonance Multimodal Imaging.Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.

P2860

Q47269748-B370322C-610F-47DE-95DA-0354D11D294B Q55348014-711FB576-D33D-43EB-B1F4-6A0747D69495

P2860

Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat.

http://www.wikidata.org/entity/Q37541992

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-angiogenic Nanotherapy In ...... sthma in the Brown Norway Rat.

@en

Anti-angiogenic Nanotherapy In ...... sthma in the Brown Norway Rat.

@nl

type

label

Anti-angiogenic Nanotherapy In ...... sthma in the Brown Norway Rat.

@en

Anti-angiogenic Nanotherapy In ...... sthma in the Brown Norway Rat.

@nl

prefLabel

Anti-angiogenic Nanotherapy In ...... sthma in the Brown Norway Rat.

@en

Anti-angiogenic Nanotherapy In ...... sthma in the Brown Norway Rat.

@nl

P1433

Q37541992-0EF8EBF7-20CE-449D-BA17-559246166E2A

P1476

Q37541992-3E9FA10B-9022-43F0-AFE0-9DDAAC7E14C5

P2093

Q37541992-03D63C7B-8BAC-417B-8934-9317B57ED423

Q37541992-09CD2812-8900-4DC5-A53C-2F22B4ABF6C1

Q37541992-17B0B8AA-3AAB-4F4A-95F9-E992A3122500

Q37541992-340F03CA-A03C-4076-9A58-514E8528B3F7

Q37541992-41DC38BB-263B-46B8-BA6A-91280DB1AAA9

Q37541992-458DB8A9-BE9B-4621-AAF8-4AE1E9D013E3

Q37541992-7AAF76B3-5836-4521-BFAF-5333C50A1DF5

Q37541992-8C61CE78-C698-48FD-90CE-2891B4EE57D7

Q37541992-9F7AC2C2-39A2-44D5-9ACB-6B138C5D0EFF

Q37541992-A6399144-E2BE-4EDA-BFB2-BE0270C464E7

P2860

Q37541992-00B4EAA5-074B-476E-8FB8-0BC5FACA3853

Q37541992-0166B626-9654-4894-8651-0C1590CE62AC

Q37541992-0DE17683-1F58-494C-B49E-F6ACDDE85DB3

Q37541992-15C2A758-9F40-44CC-B94B-927AA56AE186

Q37541992-17D121FB-91C3-4369-B863-A36F4BAC3A09

Q37541992-1C14627E-9773-4400-A637-BE1DCD4C713B

Q37541992-2A27033B-8D9B-4856-AEBE-8DA861F4B41E

Q37541992-2A5E38BA-DBD5-4E82-A853-0429E8DF6580

Q37541992-2A652042-6697-4485-B0CE-3E2872DC0710

Q37541992-2D61D268-5931-48C1-B3E2-C934F4D3623D

P304

Q37541992-46DF87BD-DD0E-45D6-991F-535BA3360FB7

P31

Q37541992-39E6EF17-B0B8-42BE-A6EF-BCCBDE7AC301

P356

Q37541992-E99D4FC2-C6ED-421E-9B08-B252AFD98244

P433

Q37541992-2ABD6A4E-1650-4929-9588-7F0433E0C801

P478

Q37541992-B4FAC801-70E0-4AA8-B8C0-8542F4E0D815

P577

Q37541992-0935B3AE-3CC3-44FF-B728-6AF22BEDC35C

P698

Q37541992-1BBB775A-707B-45FA-904B-8A88E3936706

P921

Q37541992-200F5FB0-0466-4A6F-BAB0-53CA80DE1780

P932

Q37541992-CAF9733A-5F66-4725-AF26-106289C8DB6F

P356

P1433

P1476

Anti-angiogenic Nanotherapy In ...... sthma in the Brown Norway Rat.

@en

P2093

Aigul Moldobaeva

http://www.w3.org/2001/XMLSchema#string

Anne H Schmieder

http://www.w3.org/2001/XMLSchema#string

Babak Razani

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Wagner

http://www.w3.org/2001/XMLSchema#string

Grace Cui

http://www.w3.org/2001/XMLSchema#string

Gregory M Lanza

http://www.w3.org/2001/XMLSchema#string

Huiying Zhang

http://www.w3.org/2001/XMLSchema#string

Ismail Sergin

http://www.w3.org/2001/XMLSchema#string

Jochen Keupp

http://www.w3.org/2001/XMLSchema#string

John Jenkins

http://www.w3.org/2001/XMLSchema#string

P2860

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

Update on the role of alternatively activated macrophages in asthma

Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery

Structure of human methionine aminopeptidase-2 complexed with fumagillin

Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.

Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide.

MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation.

Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

The alveolar macrophages in asthma: a double-edged sword.

alphaVbeta3-targeted copper nanoparticles incorporating an Sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment.

P304

377-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.16627

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042341

http://www.w3.org/2001/XMLSchema#string

P921

P932

5197071

http://www.w3.org/2001/XMLSchema#string